Meghan Verena Joyce - 04 Aug 2022 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Director
Signature
/s/ John Saia, as attorney-in-fact for Meghan Verena Joyce
Issuer symbol
GH
Transactions as of
04 Aug 2022
Net transactions value
$0
Form type
4
Filing time
07 Sep 2022, 16:36:55 UTC
Previous filing
17 Jun 2022
Next filing
06 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH COMMON STOCK Options Exercise $0 +796 $0.000000 796 04 Aug 2022 Direct
transaction GH COMMON STOCK Options Exercise $0 +66 +8.3% $0.000000 862 04 Sep 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH RESTRICTED STOCK UNITS Options Exercise $0 -796 -25% $0.000000 2,389 04 Aug 2022 COMMON STOCK 796 $0.000000 Direct F1, F2
transaction GH RESTRICTED STOCK UNITS Options Exercise $0 -66 -2.8% $0.000000 2,323 04 Sep 2022 COMMON STOCK 66 $0.000000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock unit vests as to 25% of the shares subject to such award on August 4, 2022, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each monthly anniversary of August 4, 2022, during the three-year period thereafter.
F2 Not applicable to Restricted Stock Units.